RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

4basebio AG announces changes to the Management Board

Abivax’s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government’s Clinical Trial Council

Apogenix AG – COVID-19: targeted treatment trial launched in Vienna

Adocia announces its financial calendar for 2021

Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones

Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China

XPHYTO Therapeutics completes successful SARS-CoV-2 RT-PCR diagnostic test kit validation

4basebio AG – Update regarding the status of the settlement of the spin-off

Marinomed Biotech AG announces grant of European Patent covering the proprietary Marinosolv® technology to generate aqueous solutions from insoluble compounds